Corneal and Conjunctival Sensitivity in Patients With Dry Eye: The Effect of Topical Cyclosporine Therapy

Purpose: To evaluate changes in mechanical sensitivity of cornea and conjunctiva in patients with dry eye disease unresponsive to artificial tears therapy and to investigate the effect of topical cyclosporine therapy on sensitivity of the ocular surface. Methods: Thirty-seven patients with dry eye disease and 35 healthy control subjects were enrolled to this prospective study. All patients included in the study completed a 3-month run-in period of using nonpreserved artificial tear supplements, but all failed to achieve adequate subjective or objective improvement. Patients were then instructed to use topical cyclosporine A 0.05% twice a day. Pre- and posttreatment (1, 3, and 6 months) evaluations included, corneal and conjunctival sensitivity testing with the Cochet-Bonnet esthesiometer, Subjective symptom scoring, fluorescein and lissamine green staining, Schirmer test, and tear breakup time (BUT). Results: Conjunctival and corneal sensitivities were significantly lower in patients with dry eye compared with controls (P 0.05). After topical cyclosporine, statistically significant improvements from baseline were observed in corneal sensitivity at 3- and 6-month visits (P < 0.001). For conjunctival sensitivity, statistically significant improvements from baseline were seen at all follow-up visits (P < 0.0001). Topical cyclosporine treatment also led to significant improvements in symptom scores, Schirmer test, tear BUT, and ocular surface staining scores (P < 0.0001). Conclusions: The mechanical sensitivity of cornea and conjunctiva to tactile stimulus is reduced in patients with dry eye. Our findings suggest that topical cyclosporine may be effective in improving this reduced mechanical sensitivity of the ocular surface